Increasing prevalence of diabetes is driving the growth in the United States blood glucose monitoring devices market in the forecast period, 2022-2026.
The growing prevalence of obesity and sedentary lifestyle among the population in the United States has led to an increase in the prevalence of various chronic diseases such as diabetes, cardiovascular diseases, among others in the country. This in turn has increased the demand for blood glucose monitoring devices market also. Besides, growing awareness among the population pertaining to preventive healthcare has further increased the demand for blood glucose monitoring devices.
Browse over 15 market data Figures spread through 70 Pages and an in-depth TOC on "United States Blood Glucose Monitoring Devices Market"
However, stringent regulatory policies for regulatory approvals can restrict the market growth through 2026. Also, frequent product recalls can further slowdown the market growth during the forecast period. Also, unfavorable reimbursement scenario also negatively impacts the market growth.
The United States blood glucose monitoring devices market is segmented based on product, application, end user, company, and regional distribution. Based on product, the market can be split into self blood glucose monitoring devices and continuous blood glucose monitoring devices. Self blood glucose monitoring devices segment dominated the market in 2020 with an overall market share of around 59.45% on account of their ease of use and low cost. Self blood glucose monitoring devices market can be further categorized into test strips, lancets, and glucometers. The test strips segment is expected to dominate the market during the forecast period on account of their widespread use, affordability, etc.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7489
Customers can also request for 10% free customization on this report.
Key market players in the United States Blood Glucose Monitoring Devices market include:
- Abbott Laboratories, Inc.
- Medtronic USA Inc.
- Roche Diagnostics Corporation
- Dexcom, Inc.
- B. Braun Medical Inc.
- Becton, Dickinson, and Company
- Sanofi-Aventis U.S. LLC
- Insulet Corporation
- Nipro Medical Corporation
- Terumo Medical Corporation
Major companies operating in the market are following strategies such as mergers & acquisitions, product launches, among others in order to stay competitive in the market and having an edge over other players operating in the market.
Press Release: https://www.techsciresearch.com/news/6632-united-states-blood-glucose-monitoring-devices-market.html
“The United States Blood Glucose Monitoring Devices Market is expected to witness growth in the coming years on account of growing prevalence of obesity, diabetes, among others among the population across the country. Furthermore, increasing penetration of retail clinics and growing awareness related to point of care testing services will further drive the market growth through 2026.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Blood Glucose Monitoring Devices Market By Product (Self Blood Glucose Monitoring Devices v/s Continuous Glucose Monitoring Devices), By Application (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospital & Clinics, Others), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of the United States blood glucose monitoring devices market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the United States blood glucose monitoring devices market.
Browse Related Reports:
United States Artificial Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026
United States Medical Aesthetic Devices Market By Type of Device (Energy-Based Aesthetic Device {Laser-Based Aesthetic Device, Radiofrequency-Based Aesthetic Device, Light-Based Aesthetic Device, Others} v/s Non-Energy-Based Aesthetic Device {Aesthetic Botulinum Toxin, Microdermabrasion, Implants, Others}) By Application (Skin Resurfacing and Tightening, Body Contouring and Cellulite Reduction, Hair Removal, Facial Aesthetic Procedures, Others) By End User (Hospitals & Clinics, Home Care Settings, Others) By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/united-states-medical-aesthetic-devices-market/7993.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
No comments:
Post a Comment